P382: PTK2B MEDIATES TYROSINE KINASE INHIBITOR DRUG RESISTANCE IN AML ASSOCIATED WITH ALTERED MIGRATION AND ADHESION PROPERTIES

• C. Allert,
• S. Zimmermann,
• S. Göllner,
• D. Heid,
• M. Bruckmann,
• M. Janssen,
• B. Besenbeck,
• J. Krijgsveld,
• C. Müller-Tidow,
• M. F. Blank

Affiliations

C. Allert

1 Medical Department V Hematology, Oncology and Rheumatology, Heidelberg University Hospital

S. Zimmermann

2 University of Heidelberg Medical Faculty

S. Göllner

1 Medical Department V Hematology, Oncology and Rheumatology, Heidelberg University Hospital

D. Heid

1 Medical Department V Hematology, Oncology and Rheumatology, Heidelberg University Hospital

M. Bruckmann

1 Medical Department V Hematology, Oncology and Rheumatology, Heidelberg University Hospital

M. Janssen

1 Medical Department V Hematology, Oncology and Rheumatology, Heidelberg University Hospital

B. Besenbeck

1 Medical Department V Hematology, Oncology and Rheumatology, Heidelberg University Hospital

J. Krijgsveld

2 University of Heidelberg Medical Faculty

C. Müller-Tidow

1 Medical Department V Hematology, Oncology and Rheumatology, Heidelberg University Hospital

M. F. Blank

1 Medical Department V Hematology, Oncology and Rheumatology, Heidelberg University Hospital